Press release
Acinetobacter Infections Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Omnix Medical, Venatorx, AiCuris, Wockhardt, Atterx, Hsiri, Antabio, Vaxdyn, Debiopharm, BioVersys
"Acinetobacter Infections Pipeline Insight, 2023" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Acinetobacter Infections Therapeutics Market.
The report provides a detailed description of the Acinetobacter Infections drugs, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any). The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.
Get a Detailed Overview of the Acinetobacter Infections Clinical Trial Activities and Regulatory Developments in the domain:
https://www.delveinsight.com/report-store/acinetobacter-infections-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Acinetobacter Infections Pipeline Analysis
The report provides insights into:
• The report provides detailed insights into the key companies that are developing Acinetobacter Infections therapies.
• The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Acinetobacter Infections treatment.
• It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• It navigates the emerging Acinetobacter Infections drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement in the Acinetobacter Infections treatment market.
Learn More about the Clinical and Commercial Development Activities in the Acinetobacter Infections Therapeutics Domain:
https://www.delveinsight.com/report-store/acinetobacter-infections-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
The Report Covers the Emerging Acinetobacter Infections Therapies Under Different Phases of Clinical Development Like -
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
Route of Administration
Acinetobacter Infections pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Oral
• Parenteral
• intravitreal
• Subretinal
• Topical
Molecule Type
Products have been categorized under various Molecule types such as
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy
Request for Sample PDF to Understand More About the Acinetobacter Infections Treatment Outlook and Future Perspectives:
https://www.delveinsight.com/sample-request/acinetobacter-infections-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Acinetobacter Infections Therapeutics Analysis
There are approx. 25+ key companies developing therapies for Acinetobacter Infections. Currently, Entasis Therapeutics is leading the therapeutics segment with its Acinetobacter Infections drug candidates in the most advanced stage of clinical development.
Acinetobacter Infections Companies in the Therapeutics Market Include:
Entasis Therapeutics, Spero Therapeutics, Omnix Medical, ABAC Therapeutics, Venatorx Pharmaceuticals, Armata Pharmaceuticals, Technophage, SA, Aridis Pharmaceuticals, Forge Therapeutics, AiCuris, Wockhardt, Tetraphase Pharmaceuticals, Geom Therapeutics, Atterx Biotherapeutics, Hsiri Therapeutics, Antabio, TAXIS Pharmaceutical, Vaxdyn, ContraFect Corporation (CFRX), Debiopharm, Idorsia, Tetraphase, Telum Therapeutics, Bioharmony Therapeutics, Destiny Pharma, BioVersys, and many more.
Emerging and Marketed Acinetobacter Infections Therapies Covered in the Report Include:
• Sulbactam-durlobactam: Entasis Therapeutics
Durlobactam (DUR; previously designated ETX2514) is a novel, broad-spectrum and potent inhibitor of Class A, C, and D β-lactamases. Sulbactam (SUL) is a β-lactam antibiotic with activity against Acinetobacter baumannii; however, β-lactamase-mediated resistance to sulbactam is now widespread rendering it generally ineffective. In preclinical studies, durlobactam inhibits the β-lactamases commonly found in A. baumannii thus restoring sulbactam's activity. The company is developing SUL-DUR (previously designated ETX2514SUL), a combination of β-lactam antibiotic and a β-lactamase inhibitor for the treatment of serious infections cuased by Acinetobacter, including multidrug-resistant (MDR) strains.
Get an in-depth Assessment of the Emerging Therapies and Acinetobacter Infections Companies Actively Working in the Market:
https://www.delveinsight.com/sample-request/acinetobacter-infections-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Table of Content
1. Report Introduction
2. Executive Summary
3. Acinetobacter Infections Current Treatment Patterns
4. Acinetobacter Infections - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Acinetobacter Infections Late-Stage Products (Phase-III)
7. Acinetobacter Infections Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Acinetobacter Infections Discontinued Products
13. Acinetobacter Infections Product Profiles
14. Acinetobacter Infections Companies
15. Acinetobacter Infections Drugs
16. Dormant and Discontinued Products
17. Acinetobacter Infections Unmet Needs
18. Acinetobacter Infections Future Perspectives
19. Acinetobacter Infections Analyst Review
20. Appendix
21. Report Methodology
Get Detailed Insights About the Reports Offerings:
https://www.delveinsight.com/sample-request/acinetobacter-infections-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
------------------------------------------------------------------------------------------------------------------------------
Healthcare Consulting and Competitive Intelligence Services by DelveInsight
Discover DelveInsight's Comprehensive Market Research and Consulting Services:
https://www.delveinsight.com/market-research
Elevate your industry insights with our comprehensive medical devices market assessment reports. Visit to gain a strategic edge through expert analysis and in-depth coverage of the latest trends, innovations, and market dynamics, at:
https://www.delveinsight.com/medical-devices
Empowering Cancer Care: DelveInsight's oncology consulting services offer personalized guidance and cutting-edge expertise to navigate the ongoing clinical, commercial, and regulatory developments, visit for more details:
https://www.delveinsight.com/oncology
Other Trending Healthcare Reports by DelveInsight
Indolent Lymphoma Market
https://www.delveinsight.com/report-store/indolent-lymphoma-market
Lipodystrophy Market
https://www.delveinsight.com/report-store/lipodystrophy-market
Vutrisiran Market
https://www.delveinsight.com/report-store/vutrisiran-market
Anaplastic Astrocytoma Market
https://www.delveinsight.com/report-store/anaplastic-astrocytoma-market
Singapore Healthcare Outlook
https://www.delveinsight.com/report-store/singapore-healthcare-outlook-report
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market
https://www.delveinsight.com/report-store/blastic-plasmacytoid-dendritic-cell-neoplasm-bpdcn-market
Chronic Idiopathic Constipation Market
https://www.delveinsight.com/report-store/chronic-idiopathic-constipation-market
Hay Fever Conjunctivitis Market
https://www.delveinsight.com/report-store/hay-fever-conjunctivitis-market
Nasopharyngeal Carcinoma Market
https://www.delveinsight.com/report-store/nasopharyngeal-carcinoma-market
Cerebral Infarction Market
https://www.delveinsight.com/report-store/cerebral-infarction-market
CART-related Neurotoxicity (NT) Market
https://www.delveinsight.com/report-store/cart-related-neurotoxicity-nt-market
Hernia Repair Devices Market
https://www.delveinsight.com/report-store/hernia-repair-devices-market
Bronchial Hyperreactivity Market
https://www.delveinsight.com/report-store/bronchial-hyperreactivity-market
Chronic Focal Epilepsy Market
https://www.delveinsight.com/report-store/chronic-focal-epilepsy-market
Dental Lasers Market
https://www.delveinsight.com/report-store/dental-lasers-market
Down Syndrome Market
https://www.delveinsight.com/report-store/down-syndrome-market
Extracorporeal Circulation System Market
https://www.delveinsight.com/report-store/extracorporeal-circulation-system-market
Failed Back Surgery Syndrome Market
https://www.delveinsight.com/report-store/failed-back-surgery-syndrome-market
Germ Cell Tumor Market
https://www.delveinsight.com/report-store/germ-cell-tumor-market
Hot Flashes Market
https://www.delveinsight.com/report-store/hot-flashes-market
India Healthcare Outlook
https://www.delveinsight.com/report-store/india-healthcare-outlook-report
Insulin Glargine Biosimilar
https://www.delveinsight.com/report-store/insulin-glargine-biosimilar-insight
Listeriosis Market
https://www.delveinsight.com/report-store/listeriosis-market
Liver Angiosarcoma Market
https://www.delveinsight.com/report-store/liver-angiosarcoma-market
Mucopolysaccharidosis I Market
https://www.delveinsight.com/report-store/mucopolysaccharidosis-i-market
Nasolabial Fold Market
https://www.delveinsight.com/report-store/nasolabial-fold-market
Neuroleptic Malignant Syndrome Market
https://www.delveinsight.com/report-store/neuroleptic-malignant-syndrome-market
Pachyonychia Congenita Market
https://www.delveinsight.com/report-store/pachyonychia-congenita-market
Point of Care Glucose Testing Market
https://www.delveinsight.com/report-store/point-of-care-glucose-testing-market
Reactive Airway Disease Market
https://www.delveinsight.com/report-store/reactive-airway-disease-market
Seborrhea Market
https://www.delveinsight.com/report-store/seborrhea-market
Substance (Drug) Abuse Market
https://www.delveinsight.com/report-store/substance-drug-abuse-market
Synchronous Endometrial and Ovarian Cancer (SEOC) Market
https://www.delveinsight.com/report-store/synchronous-endometrial-and-ovarian-cancer-seoc-market
Trastuzumab Biosimilars
https://www.delveinsight.com/report-store/trastuzumab-biosimilars-insight
Urinary Tract Infection Devices Market
https://www.delveinsight.com/report-store/urinary-tract-infection-devices-market
Varicose Veins Market
https://www.delveinsight.com/report-store/varicose-veins-market
Vulvodynia Market
https://www.delveinsight.com/report-store/vulvodynia-market
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Contact Info:
Shruti Thakur
Manager - Marketing & International Branding
Email: info@delveinsight.com
428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Acinetobacter Infections Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Omnix Medical, Venatorx, AiCuris, Wockhardt, Atterx, Hsiri, Antabio, Vaxdyn, Debiopharm, BioVersys here
News-ID: 3186280 • Views: …
More Releases from DelveInsight Business Research LLP
Colorectal Cancer Pipeline Drugs in Development Signal Major Shifts in the Treat …
DelveInsight's, "Colorectal Cancer Pipeline Insight 2025" report provides comprehensive insights about 195+ companies and 200+ pipeline drugs in Colorectal Cancer pipeline landscape. It covers the Colorectal Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Colorectal Cancer pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore our latest breakthroughs in Colorectal…
Idiopathic Pulmonary Fibrosis Pipeline Clinical Trial Insights Reveal Breakthrou …
DelveInsight's, "Idiopathic Pulmonary Fibrosis Pipeline Insights 2025" report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in Idiopathic Pulmonary Fibrosis pipeline landscape. It covers the Idiopathic Pulmonary Fibrosis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Idiopathic Pulmonary Fibrosis therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive Idiopathic Pulmonary Fibrosis pipeline products in this…
Small Cell Lung Cancer Pipeline Clinical Trials Highlight Promising Drugs in Dev …
DelveInsight's, "Small Cell Lung Cancer Pipeline Insight 2025" report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in Small Cell Lung Cancer pipeline landscape. It covers the Small Cell Lung Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Small Cell Lung Cancer pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products…
Myelofibrosis Pipeline Outlook 2025: Insights Into Therapies, Research, and Mark …
DelveInsight's, "Myelofibrosis Pipeline Insights 2025" report provides comprehensive insights about 35+ companies and 40+ pipeline drugs in Myelofibrosis pipeline landscape. It covers the Myelofibrosis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Myelofibrosis therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Stay ahead with the latest insights! Download DelveInsight's comprehensive Myelofibrosis Pipeline…
More Releases for Acinetobacter
Acinetobacter Pneumonia Therapeutics Market Revenue Report with Forecast to 2034
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Acinetobacter Pneumonia Therapeutics Market Size, Share & Trends Analysis Report By Drug Class (Cephalosporins, Carbapenems, Aminoglycosides, Polymyxins), By Route of Administration (Oral, Intravenous, Others), Region, Market Outlook And Industry Analysis 2034"
The global Acinetobacter Pneumonia Therapeutics Market Size is valued at USD 646.05 Mn in 2024 and is predicted to reach USD 1101.68 Mn by the…
Acinetobacter Pneumonia Therapeutics Market Combating a Resistant Threat Market …
Acinetobacter Pneumonia Therapeutics Market to reach over USD 927.1 Mn by the year 2031 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Acinetobacter Pneumonia Therapeutics Market Size, Share & Trends Analysis Report By Drug Class (Cephalosporins, Carbapenems, Aminoglycosides, Polymyxins), By Route of Administration (Oral, Intravenous, Others), Region, Market Outlook And Industry Analysis 2031"
The global Acinetobacter Pneumonia Therapeutics Market…
Acinetobacter Pneumonia Therapeutics Market Report Explores Reviews Analysis Rep …
Acinetobacter Pneumonia Therapeutics Market is estimated to reach over USD 927.1 Mn by 2031, exhibiting a CAGR of 5.30% during the forecast period.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Acinetobacter Pneumonia Therapeutics Market Size, Share & Trends Analysis Report By Drug Class (Cephalosporins, Carbapenems, Aminoglycosides, Polymyxins), By Route of Administration (Oral, Intravenous, Others), Region, Market Outlook And Industry Analysis 2031"
The global Acinetobacter…
Global Acinetobacter Infections Treatment Market Research Report 2020
LOS ANGELES - USA, Acinetobacter is a group of bacteria commonly found in soil and water. While there are many types or "species" of Acinetobacter and all can cause human disease, Acinetobacter baumannii accounts for about 80% of reported infections.
Outbreaks of Acinetobacter infections typically occur in intensive care units and healthcare settings housing very ill patients. Acinetobacter infections rarely occur outside of healthcare settings.
Acinetobacter is often resistant to many commonly…
Acinetobacter Infections Treatment Market with Worldwide Industry Analysis to 20 …
Global Acinetobacter Infections Treatment Market: Overview
Acinetobacter baumannii is a rod shaped gram-negative coccobacillus bacterium. This bacterium is becoming an important cause of hospital derived bacterial infection affecting people with weakened immune system. Acinetobacter infections usually affect organ systems, which have a high content of fluid (e.g. peritoneal fluid, respiratory tract, urinary tract, cerebrospinal fluid etc.) leading to infections related to continuous ambulatory peritoneal dialysis and nocosomial pneumonia. At present,…
Acinetobacter Infections - Pipeline Review, H1 2017 - Pharmaceutical Market Repo …
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acinetobacter Infections - Pipeline Review, H1 2017, provides an overview of the Acinetobacter Infections (Infectious Disease) pipeline landscape.
Acinetobacter is a gram-negative coccobacillus. Acinetobacter infections are uncommon but, when they occur, usually involve organ systems that have a high fluid content (respiratory tract, CSF, peritoneal fluid, urinary tract). Symptoms include fever (high body temperature), red, swollen, warm or painful skin areas…
